The NSW Government’s is backing medical technology company Nanosonics to more than double its manufacturing capacity and bolster R&D investment in new innovations.
Premier Dominic Perrottet said the support from the $250 million Jobs Plus Program would help create over 100 new direct jobs and support over 300 new indirect jobs by June 2024.
“This support continues our investment and leadership in the critical medical technology and health innovation industries that will help both safeguard citizens and fuel our economic recovery,” Mr Perrottet said.
“By supporting Nanosonics’ expansion, we are creating new jobs and opportunities within the state and helping drive the company’s international expansion.”
Nanosonics currently manufactures and distributes the trophon technology for the decontamination of ultrasound probes. There are an estimated 150 different medical procedures that use ultrasound probes and Nanosonics’ innovative disinfection devices greatly reduce the risk of infection.
The company’s recent innovation includes new automated technology designed to address one of the most significant challenges in medical instrument reprocessing today, the decontamination of reusable flexible endoscopes.
Nanosonics CEO Michael Kavanagh said the company’s new headquarters will enable increased capacity of all functions of the business, in particular R&D and manufacturing, with new state-of-the-art laboratories being established to support further innovation in infection prevention.
“Nanosonics has reached an exciting phase in its global growth trajectory and this support will help take our manufacturing capacity, as well as important R&D, to a new level of operation,” Mr Kavanagh said.
“The business continues to expand its Nanosonics’ trophon disinfection franchise internationally and has recently launched a new digital compliance and traceability platform in infection prevention.”
